NDC 87628-101 – Varubi
Rolapitant Hydrochloride 90 mg/1 · Tablet · Oral
Product NDC87628-101
Product details
- Brand name
- Varubi
- Generic name
- Rolapitant
- Labeler
- Luria Therapeutics LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA206500
- Marketed since
- August 20, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Rolapitant Hydrochloride 90 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 87628-101-02 | 2 TABLET in 1 BLISTER PACK (87628-101-02) | Sep 8, 2026 |
Other Varubi products
- 70720-101 Rolapitant Hydrochloride 90 mg/1 · Tablet · TerSera Therapeutics LLC